 |
28 Diseases |  |
17 Trials |
|
17 Trials |  |
1171 News |  |
| «12...234567891011121314 |
- ||||||| fexofenadine / Generic mfg.
Trial completion: Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma (clinicaltrials.gov) - Feb 22, 2014
P3, N=1000, Completed, Sponsor: Sanofi
No longer recruiting --> Completed
- Trial completion: Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria (clinicaltrials.gov) - Feb 15, 2014
P4, N=150, Completed, Sponsor: Grupo de Alergolog
No longer recruiting --> Completed Active, not recruiting --> Completed
- New P1 trial: Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers (clinicaltrials.gov) - Feb 4, 2014
P1, N=30, Completed, Sponsor: Chonbuk National University Hospital
- | New P4 trial: Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria (clinicaltrials.gov) - Sep 10, 2013
P4, N=150, Completed, Sponsor: Grupo de Alergolog
- fexofenadine / Generic mfg.
Trial completion: Vitamin D3, Folic Acid and Fexofenadine in Healthy Volunteers (clinicaltrials.gov) - Aug 8, 2013
P1, N=10, Completed, Sponsor: University of Zurich
Active, not recruiting --> Completed Recruiting --> Completed
- ||| fexofenadine / Generic mfg.
New P1 trial: Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting Condition (clinicaltrials.gov) - Jun 26, 2013
P1, N=80, Completed, Sponsor: Dr. Reddy's Laboratories Limited
- Enrollment closed: Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot (clinicaltrials.gov) - Jun 19, 2013
P1, N=10, Active, not recruiting, Sponsor: Jules Desmeules
Recruiting --> Completed Recruiting --> Active, not recruiting
- fexofenadine / Generic mfg.
New P1 trial: Vitamin D3, Folic Acid and Fexofenadine in Healthy Volunteers (clinicaltrials.gov) - May 15, 2013
P1, N=10, Completed, Sponsor: University of Zurich
- | pregabalin / Generic mfg.
New P4 trial: Pregabalin for the Treatment of Uremic Pruritus (clinicaltrials.gov) - May 9, 2013
P4, N=210, Not yet recruiting, Sponsor: National Taiwan University Hospital
- fexofenadine / Generic mfg.
Clinical: DPF: Dose Proportionality of Fexofenadine in Healthy Human Egyptian Volunteers (clinicaltrials.gov) - Jan 10, 2013
P=N/A, N=25, Completed, Sponsor: Damanhour University
- New P1 trial: Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot (clinicaltrials.gov) - Nov 19, 2012
P1, N=10, Active, not recruiting, Sponsor: Jules Desmeules
- fexofenadine / Generic mfg., prednisone / Generic mfg.
New P2 trial: Aprepitant in the Management of Biological Therapies-related Severe Pruritus (clinicaltrials.gov) - Sep 10, 2012
P2, N=45, Completed, Sponsor: Campus Bio-Medico University
- fexofenadine / Generic mfg., levocetirizine / Generic mfg.
New P1 trial: LAWAF: Safety Study of Levocetirizine and Fexofenadine (clinicaltrials.gov) - Apr 22, 2012
P1, N=18, Completed, Sponsor: Charite University, Berlin, Germany
- |||| fexofenadine / Generic mfg., loratadine / Generic mfg.
Trial completion: A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712) (clinicaltrials.gov) - Dec 7, 2011
P4, N=255, Completed, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||| fexofenadine / Generic mfg., loratadine / Generic mfg.
New P4 trial: A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712) (clinicaltrials.gov) - Nov 8, 2011
P4, N=255, Completed, Sponsor: Merck Sharp & Dohme Corp.
- ||||||| fexofenadine / Generic mfg.
Trial completion: Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD) (clinicaltrials.gov) - Sep 12, 2011
P2/3, N=100, Completed, Sponsor: Sanofi
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| fexofenadine / Generic mfg.
Trial completion: Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR) (clinicaltrials.gov) - Sep 12, 2011
P2/3, N=100, Completed, Sponsor: Sanofi
Active, not recruiting --> Completed Active, not recruiting --> Completed